nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—Faecal incontinence—Vandetanib—thyroid cancer	0.0732	0.0732	CcSEcCtD
Pyridostigmine—Lethargy—Vandetanib—thyroid cancer	0.0273	0.0273	CcSEcCtD
Pyridostigmine—Cardiac arrest—Vandetanib—thyroid cancer	0.0255	0.0255	CcSEcCtD
Pyridostigmine—Blood pressure increased—Sorafenib—thyroid cancer	0.0249	0.0249	CcSEcCtD
Pyridostigmine—Dry skin—Vandetanib—thyroid cancer	0.0246	0.0246	CcSEcCtD
Pyridostigmine—Bronchitis—Vandetanib—thyroid cancer	0.0223	0.0223	CcSEcCtD
Pyridostigmine—Pollakiuria—Vandetanib—thyroid cancer	0.0214	0.0214	CcSEcCtD
Pyridostigmine—Epistaxis—Vandetanib—thyroid cancer	0.0195	0.0195	CcSEcCtD
Pyridostigmine—Bradycardia—Vandetanib—thyroid cancer	0.0189	0.0189	CcSEcCtD
Pyridostigmine—Dry skin—Sorafenib—thyroid cancer	0.0166	0.0166	CcSEcCtD
Pyridostigmine—Alopecia—Vandetanib—thyroid cancer	0.0164	0.0164	CcSEcCtD
Pyridostigmine—Lacrimation—Epirubicin—thyroid cancer	0.0157	0.0157	CcSEcCtD
Pyridostigmine—Muscle spasms—Vandetanib—thyroid cancer	0.0155	0.0155	CcSEcCtD
Pyridostigmine—Lacrimation—Doxorubicin—thyroid cancer	0.0145	0.0145	CcSEcCtD
Pyridostigmine—Loss of consciousness—Vandetanib—thyroid cancer	0.0142	0.0142	CcSEcCtD
Pyridostigmine—Convulsion—Vandetanib—thyroid cancer	0.014	0.014	CcSEcCtD
Pyridostigmine—Epistaxis—Sorafenib—thyroid cancer	0.0131	0.0131	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.012	0.012	CcSEcCtD
Pyridostigmine—Amblyopia—Epirubicin—thyroid cancer	0.0119	0.0119	CcSEcCtD
Pyridostigmine—Paraesthesia—Vandetanib—thyroid cancer	0.0118	0.0118	CcSEcCtD
Pyridostigmine—Alopecia—Sorafenib—thyroid cancer	0.0111	0.0111	CcSEcCtD
Pyridostigmine—Amblyopia—Doxorubicin—thyroid cancer	0.011	0.011	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0108	0.0108	CcSEcCtD
Pyridostigmine—Muscle spasms—Sorafenib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Pyridostigmine—Abdominal pain—Vandetanib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Pyridostigmine—Lacrimation increased—Epirubicin—thyroid cancer	0.00999	0.00999	CcSEcCtD
Pyridostigmine—Loss of consciousness—Sorafenib—thyroid cancer	0.00957	0.00957	CcSEcCtD
Pyridostigmine—Asthenia—Vandetanib—thyroid cancer	0.00945	0.00945	CcSEcCtD
Pyridostigmine—Neck pain—Epirubicin—thyroid cancer	0.00932	0.00932	CcSEcCtD
Pyridostigmine—Myalgia—Sorafenib—thyroid cancer	0.00927	0.00927	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—thyroid cancer	0.00924	0.00924	CcSEcCtD
Pyridostigmine—Diarrhoea—Vandetanib—thyroid cancer	0.00901	0.00901	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00894	0.00894	CcSEcCtD
Pyridostigmine—Neck pain—Doxorubicin—thyroid cancer	0.00862	0.00862	CcSEcCtD
Pyridostigmine—Vomiting—Vandetanib—thyroid cancer	0.00837	0.00837	CcSEcCtD
Pyridostigmine—Rash—Vandetanib—thyroid cancer	0.0083	0.0083	CcSEcCtD
Pyridostigmine—Dermatitis—Vandetanib—thyroid cancer	0.0083	0.0083	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00827	0.00827	CcSEcCtD
Pyridostigmine—Headache—Vandetanib—thyroid cancer	0.00825	0.00825	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Epirubicin—thyroid cancer	0.00819	0.00819	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0081	0.0081	CcSEcCtD
Pyridostigmine—Hypertonia—Epirubicin—thyroid cancer	0.00807	0.00807	CcSEcCtD
Pyridostigmine—Nausea—Vandetanib—thyroid cancer	0.00782	0.00782	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Epirubicin—thyroid cancer	0.00772	0.00772	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00758	0.00758	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—thyroid cancer	0.00746	0.00746	CcSEcCtD
Pyridostigmine—Eye pain—Epirubicin—thyroid cancer	0.0074	0.0074	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00727	0.00727	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00714	0.00714	CcSEcCtD
Pyridostigmine—Urticaria—Sorafenib—thyroid cancer	0.00706	0.00706	CcSEcCtD
Pyridostigmine—Abdominal pain—Sorafenib—thyroid cancer	0.00702	0.00702	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—thyroid cancer	0.00685	0.00685	CcSEcCtD
Pyridostigmine—Lethargy—Epirubicin—thyroid cancer	0.00682	0.00682	CcSEcCtD
Pyridostigmine—Hypersensitivity—Sorafenib—thyroid cancer	0.00655	0.00655	CcSEcCtD
Pyridostigmine—Asthenia—Sorafenib—thyroid cancer	0.00637	0.00637	CcSEcCtD
Pyridostigmine—Cardiac arrest—Epirubicin—thyroid cancer	0.00635	0.00635	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—thyroid cancer	0.00631	0.00631	CcSEcCtD
Pyridostigmine—Dry skin—Epirubicin—thyroid cancer	0.00612	0.00612	CcSEcCtD
Pyridostigmine—Diarrhoea—Sorafenib—thyroid cancer	0.00608	0.00608	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—thyroid cancer	0.00588	0.00588	CcSEcCtD
Pyridostigmine—Abdominal distension—Epirubicin—thyroid cancer	0.00581	0.00581	CcSEcCtD
Pyridostigmine—Asthma—Epirubicin—thyroid cancer	0.00577	0.00577	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—thyroid cancer	0.00567	0.00567	CcSEcCtD
Pyridostigmine—Vomiting—Sorafenib—thyroid cancer	0.00565	0.00565	CcSEcCtD
Pyridostigmine—Rash—Sorafenib—thyroid cancer	0.0056	0.0056	CcSEcCtD
Pyridostigmine—Dermatitis—Sorafenib—thyroid cancer	0.0056	0.0056	CcSEcCtD
Pyridostigmine—Headache—Sorafenib—thyroid cancer	0.00557	0.00557	CcSEcCtD
Pyridostigmine—Bronchitis—Epirubicin—thyroid cancer	0.00555	0.00555	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—thyroid cancer	0.00538	0.00538	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—thyroid cancer	0.00534	0.00534	CcSEcCtD
Pyridostigmine—Pollakiuria—Epirubicin—thyroid cancer	0.00533	0.00533	CcSEcCtD
Pyridostigmine—Nausea—Sorafenib—thyroid cancer	0.00528	0.00528	CcSEcCtD
Pyridostigmine—Drowsiness—Epirubicin—thyroid cancer	0.00515	0.00515	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—thyroid cancer	0.00514	0.00514	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—thyroid cancer	0.00494	0.00494	CcSEcCtD
Pyridostigmine—Epistaxis—Epirubicin—thyroid cancer	0.00486	0.00486	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—thyroid cancer	0.00476	0.00476	CcSEcCtD
Pyridostigmine—Bradycardia—Epirubicin—thyroid cancer	0.00471	0.00471	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Epirubicin—thyroid cancer	0.0046	0.0046	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—thyroid cancer	0.00449	0.00449	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—thyroid cancer	0.00435	0.00435	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00426	0.00426	CcSEcCtD
Pyridostigmine—Alopecia—Epirubicin—thyroid cancer	0.00408	0.00408	CcSEcCtD
Pyridostigmine—Flatulence—Epirubicin—thyroid cancer	0.00396	0.00396	CcSEcCtD
Pyridostigmine—Muscle spasms—Epirubicin—thyroid cancer	0.00387	0.00387	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—thyroid cancer	0.00378	0.00378	CcSEcCtD
Pyridostigmine—Agitation—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—thyroid cancer	0.00367	0.00367	CcSEcCtD
Pyridostigmine—Vertigo—Epirubicin—thyroid cancer	0.00361	0.00361	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—thyroid cancer	0.00358	0.00358	CcSEcCtD
Pyridostigmine—Loss of consciousness—Epirubicin—thyroid cancer	0.00354	0.00354	CcSEcCtD
Pyridostigmine—Convulsion—Epirubicin—thyroid cancer	0.00349	0.00349	CcSEcCtD
Pyridostigmine—Myalgia—Epirubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Pyridostigmine—Vertigo—Doxorubicin—thyroid cancer	0.00334	0.00334	CcSEcCtD
Pyridostigmine—Confusional state—Epirubicin—thyroid cancer	0.00331	0.00331	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00327	0.00327	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—thyroid cancer	0.00323	0.00323	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Epirubicin—thyroid cancer	0.00317	0.00317	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—thyroid cancer	0.00317	0.00317	CcSEcCtD
Pyridostigmine—Hypotension—Epirubicin—thyroid cancer	0.00307	0.00307	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00299	0.00299	CcSEcCtD
Pyridostigmine—Paraesthesia—Epirubicin—thyroid cancer	0.00295	0.00295	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00294	0.00294	CcSEcCtD
Pyridostigmine—Somnolence—Epirubicin—thyroid cancer	0.00292	0.00292	CcSEcCtD
Pyridostigmine—Hypotension—Doxorubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—thyroid cancer	0.00273	0.00273	CcSEcCtD
Pyridostigmine—Feeling abnormal—Epirubicin—thyroid cancer	0.00271	0.00271	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—thyroid cancer	0.0027	0.0027	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00269	0.00269	CcSEcCtD
Pyridostigmine—Urticaria—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Pyridostigmine—Abdominal pain—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Pyridostigmine—Feeling abnormal—Doxorubicin—thyroid cancer	0.0025	0.0025	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00248	0.00248	CcSEcCtD
Pyridostigmine—Hypersensitivity—Epirubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Pyridostigmine—Urticaria—Doxorubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Pyridostigmine—Abdominal pain—Doxorubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Pyridostigmine—Asthenia—Epirubicin—thyroid cancer	0.00236	0.00236	CcSEcCtD
Pyridostigmine—Diarrhoea—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Pyridostigmine—Asthenia—Doxorubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Pyridostigmine—Vomiting—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Pyridostigmine—Diarrhoea—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Pyridostigmine—Rash—Epirubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Pyridostigmine—Dermatitis—Epirubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Pyridostigmine—Headache—Epirubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Pyridostigmine—Nausea—Epirubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Pyridostigmine—Rash—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Pyridostigmine—Nausea—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
